Antimicrobials and QT prolongation

Association of macrolides with overall mortality and cardiac death among patients with various infections: A meta-analysis

(2016) Xiang Li et al.   European Journal of Internal Medicine

Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects

(2016) Borje Darpo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Which QT Correction Formulae to Use for QT Monitoring?

(2016) Bert Vandenberk et al.   Journal of the American Heart Association

Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center

(2015) Rachael A. Lee et al.   Journal of Hospital Medicine

Comparison of Formulas for Calculation of the Corrected QT Interval in Infants and Young Children

(2015) Derek Q. Phan et al.   JOURNAL OF PEDIATRICS

The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk

(2015) Yun-Jiu Cheng et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channels

(2014) W J Crumb   BRITISH JOURNAL OF PHARMACOLOGY

Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients

(2014) James E. Tisdale et al.  

Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia

(2014) Eric M. Mortensen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibiotic-induced Cardiac Arrhythmias

(2013) Elsayed Abo-Salem et al.   Cardiovascular Therapeutics

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

(2012) Leyla Asadi et al.   CLINICAL INFECTIOUS DISEASES

Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor

(2012) M. Sharma et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Azithromycin and the Risk of Cardiovascular Death

(2012) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fluconazole inhibits hERG K+ channel by direct block and disruption of protein trafficking

(2010) Shengna Han et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms: Implications for Blinding in Active-Controlled Cardiac Repolarization Studies

(2010) Jay W. Mason et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period

(2008) Emanuel Raschi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY